Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

50%(3 trials)

Phase Distribution

Ph not_applicable

83%

Ph phase_4

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (16.7%)

N/A5 (83.3%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery

NCT00544713

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01738607Not Applicable

Dietary Fiber for Fecal Incontinence

Completed

NCT02420834Not Applicable

Dry Eye Treatment With Artificial Tears

Completed

NCT01959854Not Applicable

Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye

Completed

NCT01280110Phase 4

The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients

Completed

NCT00544713Not Applicable

Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery

Completed

NCT00514852Not Applicable

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6